Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 30th:
Imprimis Pharmaceuticals, Inc. : This pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessedthe Zacks Consensus Estimate for its current year earnings rising 10.7% over the last 60 days.
Imprimis Pharmaceuticals’ shares gained 62.2% over the last three months higher than S&P 500’s gains of 5%. The company possesses a Momentum Score of A.
Parker-Hannifin Corporation (PH - Free Report) : This manufacturer of motion control products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.2% over the last 60 days.
Parker-Hannifin’s shares gained 13.7% over the last three months. The company possesses a Momentum Score of A.
DST Systems, Inc. : This technology-based information processing solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.
DST Systems’ shares gained 12.7% over the last three months. The company possesses a Momentum Score of A.
Merit Medical Systems, Inc. (MMSI - Free Report) : This medical products manufacturer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 60 days.
Merit Medical Systems’ shares gained 8.5% over the last three months. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here
Want to see all of today's Zacks Strong Buys?
Today's 5 additions are just the appetizer. You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research.See the stocks free >>.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 30th:
Imprimis Pharmaceuticals, Inc. : This pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessedthe Zacks Consensus Estimate for its current year earnings rising 10.7% over the last 60 days.
Imprimis Pharmaceuticals’ shares gained 62.2% over the last three months higher than S&P 500’s gains of 5%. The company possesses a Momentum Score of A.
Parker-Hannifin Corporation (PH - Free Report) : This manufacturer of motion control products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.2% over the last 60 days.
Parker-Hannifin’s shares gained 13.7% over the last three months. The company possesses a Momentum Score of A.
DST Systems, Inc. : This technology-based information processing solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.
DST Systems’ shares gained 12.7% over the last three months. The company possesses a Momentum Score of A.
Merit Medical Systems, Inc. (MMSI - Free Report) : This medical products manufacturer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 60 days.
Merit Medical Systems’ shares gained 8.5% over the last three months. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here
Want to see all of today's Zacks Strong Buys?
Today's 5 additions are just the appetizer. You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research.See the stocks free >>.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PH - FREE
Get the latest research report on MMSI - FREE